To review the use of the insulin-sensitizing agent metformin in women with polycystic ovary syndrome (PCOS).
DATA SOURCES:
Biomedical literature was accessed through MEDLINE (1996–March 2001) and the Iowa Drug Information Service. Key terms included metformin and polycystic ovary syndrome.
DATA SYNTHESIS:
A number of small clinical studies have examined the use of metformin in the treatment of PCOS. Women treated with metformin demonstrated normalization of endocrine function with minimal adverse effects.
CONCLUSIONS:
Metformin can be beneficial in normalizing menstrual irregularities and stimulating ovulation in previously anovulatory women. Metformin therapy is well tolerated by the majority of patients and should be considered for use in women with PCOS.
Diamanti-KandarakisEKouliCTsianateliTBergieleA. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol1998; 138: 269–74.
LoboRACarminaE. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med2000; 132: 989–93.
4.
FranksSGilling-SmithCWatsonHWillisD. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am1999; 29: 361–78.
5.
VelazquezEMMendozaSHamerTSosaFGlueckCJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism1994; 43: 647–54.
6.
Morin-PapunenLCKoivunenRMRuokonenAMarikainenHK. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril1998; 69: 691–6.
7.
MoghettiPCastelloRNegriCTosiFPerroneFCaputoM. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab2000; 85: 139–46.
8.
PirwanyIRYatesRWSCameronITFlemingR. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhea. Hum Reprod1999; 14: 2963–8.
9.
GlueckCJWangPFontaineRTracyTSieve-SmithL. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism1999; 48: 511–9.
10.
PasqualiRGambineriABiscottiDVicennatiVGagliardiLColittaD. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab2000; 85: 2767–74.
11.
GlueckCJPhillipsHCameronDSieve-SmithLWangP. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: A pilot study. Fertil Steril2001; 75: 46–52.
12.
VandermolenDTRattsVSEvansWSStovallDWKaumaSWNestlerJE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril2001; 75: 310–5.
13.
StadtmauerLATomaSKRiehlRMTalbertLM. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril2001; 75: 505–9.
14.
KolodziejczykBDulebaAJSpaczynskiRZPawelczykL. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril2000; 73: 1149–54.
15.
Morin-PapunenLCKoivunenRMRuokonenAMartikainenHK. Endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril1998; 69: 691–6.
16.
EhrmannDACavaghanMKImperialJSturisJRosenfieldRLPolonskyKS. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab1997; 82: 524–30.
17.
AcbayOGundogduS. Can metformin reduce insulin resistance in polycystic ovary syndrome?Fertil Steril1996;65: 946–9.
18.
AzzizREhrmannDLegroRSWhitcombRWHanleyRFereshetianAG. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab2001; 86: 1626–32.
